These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2591531)
21. Suramin, a protein kinase C inhibitor, impairs hepatic regeneration. Daller JA; Buckley AR; Van Hook FW; Buckley DJ; Putnam CW Cell Growth Differ; 1994 Jul; 5(7):761-7. PubMed ID: 7947391 [TBL] [Abstract][Full Text] [Related]
22. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)]. Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172 [TBL] [Abstract][Full Text] [Related]
23. Role of ceramide in suramin-induced cancer cell death. Gill JS; Windebank AJ Cancer Lett; 1997 Nov; 119(2):169-76. PubMed ID: 9570368 [TBL] [Abstract][Full Text] [Related]
25. The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiation of human neural crest-derived cell lineages. Parodi MT; Varesio L; Tonini GP FEBS Lett; 1990 Aug; 269(1):4-6. PubMed ID: 2387413 [TBL] [Abstract][Full Text] [Related]
26. Neurotoxic effect of statins on mouse neuroblastoma NB2a cell line. Vural K; Tuğlu MI Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):985-91. PubMed ID: 22013720 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues. Marchetti D; Reiland J; Erwin B; Roy M Int J Cancer; 2003 Mar; 104(2):167-74. PubMed ID: 12569571 [TBL] [Abstract][Full Text] [Related]
28. A suramin derivative induces enterocyte-like differentiation of human colon cancer cells without lysosomal storage disorder. Baghdiguian S; Nickel P; Marvaldi J; Fantini J Anticancer Drugs; 1990 Oct; 1(1):59-66. PubMed ID: 2131040 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds. Brunner G; Zalkow L; Burgess E; Rifkin DB; Wilson EL; Gruszecka-Kowalik E; Powis G Anticancer Res; 1996; 16(5A):2513-6. PubMed ID: 8917344 [TBL] [Abstract][Full Text] [Related]
31. Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro. Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Peters HA; Klijn JG Br J Cancer; 1993 Feb; 67(2):232-6. PubMed ID: 8431356 [TBL] [Abstract][Full Text] [Related]
32. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen. Boylan M; van den Berg HW; Lynch M Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667 [TBL] [Abstract][Full Text] [Related]
33. [Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6]. Baghdiguian S; Pichon J; Marvaldi J; Fantini J Bull Cancer; 1991; 78(9):807-17. PubMed ID: 1751832 [TBL] [Abstract][Full Text] [Related]
34. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines. Sandgren S; Belting M Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375 [TBL] [Abstract][Full Text] [Related]
35. [Suramin activity in human head and neck squamous cell carcinoma cell lines]. Li AT Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):108-9, 125. PubMed ID: 8217281 [TBL] [Abstract][Full Text] [Related]
36. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688 [TBL] [Abstract][Full Text] [Related]
37. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation. Ben-Baruch N; Reinhold WC; Alexandrova N; Ichinose I; Blake M; Trepel JB; Zajac-Kaye M Mol Pharmacol; 1994 Jul; 46(1):73-8. PubMed ID: 8058059 [TBL] [Abstract][Full Text] [Related]
38. Effects of trapidil and suramin on growth factor-induced calcium response and tyrosine phosphorylation in human glioma cells. Bando K; Kannuki S; Rokutan K; Shouno M; Matsumoto K Neurol Med Chir (Tokyo); 1995 Sep; 35(9):631-8. PubMed ID: 7566395 [TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro. Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660 [TBL] [Abstract][Full Text] [Related]
40. Effect of suramin on p34cdc2 kinase in vitro and in extracts from human H69 cells: evidence for a double mechanism of action. Bojanowski K; Nishio K; Fukuda M; Larsen AK; Saijo N Biochem Biophys Res Commun; 1994 Sep; 203(3):1574-80. PubMed ID: 7945307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]